Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.336, 2001-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Alternate-day dornase alfa acceptable in cystic fibrosis
Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. :
Access to resources
Recommend
Dornase alfa shows promise for treating critical lung atelectasis and mucus plugging
Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. :
Drug Disposition in Cystic Fibrosis
By Rey E. Tréluyer J-M. Pons G.
Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. :
Nebulized Antibiotics in Cystic Fibrosis
Pediatric Drugs, Vol. 4, Iss. 7, 2002-01 ,pp. :
Non-cystic fibrosis bronchiectasis
Clinical Medicine, Vol. 9, Iss. 2, 2009-04 ,pp. :